CATCH-UP vaccines: protocol for a randomized controlled trial using the multiphase optimization strategy (MOST) framework to evaluate education interventions to increase COVID-19 vaccine uptake in Oklahoma

Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multipha...

Full description

Saved in:
Bibliographic Details
Published inBMC public health Vol. 23; no. 1; pp. 1146 - 11
Main Authors Janitz, Amanda E., Neil, Jordan M., Bray, Laura A., Jervis, Lori L., Ross, Laura, Campbell, Janis E., Doescher, Mark P., Spicer, Paul G., Williams, Mary L., Lopez, April K., Uribe-Frias, Conce A., Chen, Sixia, James, Judith A., VanWagoner, Timothy M.
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 14.06.2023
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma. Our study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization). Because of Oklahoma's higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study. ClinicalTrials.gov: NCT05236270, First Posted: February 11, 2022, Last Update Posted: August 31, 2022.
AbstractList Abstract Background Oklahoma’s cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma. Methods Our study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization). Discussion Because of Oklahoma’s higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study. Trial Registration ClinicalTrials.gov: NCT05236270, First Posted: February 11, 2022, Last Update Posted: August 31, 2022.
BackgroundOklahoma’s cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma.MethodsOur study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization).DiscussionBecause of Oklahoma’s higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study.Trial RegistrationClinicalTrials.gov: NCT05236270, First Posted: February 11, 2022, Last Update Posted: August 31, 2022.
Background Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma. Methods Our study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization). Discussion Because of Oklahoma's higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study. Trial Registration ClinicalTrials.gov: NCT05236270, First Posted: February 11, 2022, Last Update Posted: August 31, 2022. Keywords: Multiphase optimization strategy, COVID-19, Vaccine hesitancy, Underserved communities, Rural health disparities, Community-engaged intervention
Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma.BACKGROUNDOklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma.Our study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization).METHODSOur study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization).Because of Oklahoma's higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study.DISCUSSIONBecause of Oklahoma's higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study.ClinicalTrials.gov: NCT05236270, First Posted: February 11, 2022, Last Update Posted: August 31, 2022.TRIAL REGISTRATIONClinicalTrials.gov: NCT05236270, First Posted: February 11, 2022, Last Update Posted: August 31, 2022.
Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma. Our study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization). Because of Oklahoma's higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study. ClinicalTrials.gov: NCT05236270, First Posted: February 11, 2022, Last Update Posted: August 31, 2022.
Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma. Our study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization). Because of Oklahoma's higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study.
ArticleNumber 1146
Audience Academic
Author Janitz, Amanda E.
James, Judith A.
Neil, Jordan M.
Spicer, Paul G.
Williams, Mary L.
Doescher, Mark P.
Bray, Laura A.
Ross, Laura
Lopez, April K.
Chen, Sixia
Jervis, Lori L.
Campbell, Janis E.
Uribe-Frias, Conce A.
VanWagoner, Timothy M.
Author_xml – sequence: 1
  givenname: Amanda E.
  surname: Janitz
  fullname: Janitz, Amanda E.
– sequence: 2
  givenname: Jordan M.
  surname: Neil
  fullname: Neil, Jordan M.
– sequence: 3
  givenname: Laura A.
  surname: Bray
  fullname: Bray, Laura A.
– sequence: 4
  givenname: Lori L.
  surname: Jervis
  fullname: Jervis, Lori L.
– sequence: 5
  givenname: Laura
  surname: Ross
  fullname: Ross, Laura
– sequence: 6
  givenname: Janis E.
  surname: Campbell
  fullname: Campbell, Janis E.
– sequence: 7
  givenname: Mark P.
  surname: Doescher
  fullname: Doescher, Mark P.
– sequence: 8
  givenname: Paul G.
  surname: Spicer
  fullname: Spicer, Paul G.
– sequence: 9
  givenname: Mary L.
  surname: Williams
  fullname: Williams, Mary L.
– sequence: 10
  givenname: April K.
  surname: Lopez
  fullname: Lopez, April K.
– sequence: 11
  givenname: Conce A.
  surname: Uribe-Frias
  fullname: Uribe-Frias, Conce A.
– sequence: 12
  givenname: Sixia
  surname: Chen
  fullname: Chen, Sixia
– sequence: 13
  givenname: Judith A.
  surname: James
  fullname: James, Judith A.
– sequence: 14
  givenname: Timothy M.
  surname: VanWagoner
  fullname: VanWagoner, Timothy M.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37316843$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1u3CAUha0qVfPTvkAXFVI36cKpwcbgbqLR9C9SqqnUpFuE8WWGxIYp4InSd-w7FWeSNomqigVw-e6Bg85-tmOdhSx7iYsjjHn9NmDCeZMXpMxxXTCWXz3J9nDFcE4qynfurXez_RAuigIzTsmzbLdkJa55Ve5lv-azs_nn_Pwr2kiljIXwDq29i065HmnnkURe2s4N5id0SDkbvev7tIzeyB6NwdgliitAw9hHs17JAMito0m8jMZZFKKXEZbX6PDL4tvZG6S9HODK-UsUHYKN7Md0jKAb1ZY3NoLfgJ02YWKMVR4m2fni-8n7HDd3L0XjOspLSABaXPZy5Qb5PHuqZR_gxe18kJ1__DD5O118OpnPTnNF6yrmlcaKlRSzRjdVQ3QrSwa0YTVuK051m6ptW0NbV6XuKOka4LXsKq7ajnSqVOVBdrLV7Zy8EGtvBumvhZNG3BScXwrpo1E9CF0qraiEouNVVReSA5Wq0S0hDWcYk6R1vNVaj-0AnUrWvewfiD48sWYllm4jcEFqSilPCoe3Ct79GCFEMZigoO-lBTcGQTipCWa0mS57_Qi9cKO36a8mihUl54z_pZYyOTBWu3SxmkTFjNVVgasmJeggO_oHlUYHg0lJAW1S_UHDq_tO_1i8S2MC-BZQ3oXgQQtl4k0skrLpk2MxBV9sgy9S8MVN8MVVaiWPWu_U_9P0G2a5CUM
CitedBy_id crossref_primary_10_1371_journal_pone_0300872
crossref_primary_10_3389_fpubh_2024_1291332
Cites_doi 10.1023/B:PREV.0000037641.26017.00
10.1016/j.vaccine.2022.12.050
10.1007/s40615-022-01471-8
10.1080/13548506.2020.1750663
10.1111/jrh.12481
10.1111/jrh.12555
10.1186/s12889-022-12900-y
10.1186/s13012-014-0169-x
10.1370/afm.1624
10.1177/2333721420936168
10.1016/j.japh.2022.01.013
10.1371/journal.pone.0248542
10.1186/s12889-022-13576-0
10.1016/j.vaccine.2022.07.045
10.1016/j.ypmed.2022.107415
10.3122/jabfm.2008.04.080006
10.3122/jabfm.2017.05.170035
10.1057/s41599-022-01439-3
10.1007/s10461-015-1145-4
10.2196/39109
10.15585/mmwr.mm7006e3
ContentType Journal Article
Copyright 2023. The Author(s).
COPYRIGHT 2023 BioMed Central Ltd.
2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2023
Copyright_xml – notice: 2023. The Author(s).
– notice: COPYRIGHT 2023 BioMed Central Ltd.
– notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2023
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T2
7X7
7XB
88E
8C1
8FE
8FG
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
AN0
ATCPS
AZQEC
BENPR
BGLVJ
BHPHI
C1K
CCPQU
COVID
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
L6V
M0S
M1P
M7S
PATMY
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
7X8
5PM
DOA
DOI 10.1186/s12889-023-16077-w
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health and Safety Science Abstracts (Full archive)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
ProQuest SciTech Collection
ProQuest Technology Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
British Nursing Database
Agricultural & Environmental Science Collection
ProQuest Central Essentials
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
ProQuest Health & Medical Collection
Medical Database
Engineering Database
Environmental Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
ProQuest Engineering Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Agricultural & Environmental Science Collection
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Engineering Database
ProQuest Public Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
Coronavirus Research Database
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Environmental Science Collection
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
Environmental Science Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database

MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Education
EISSN 1471-2458
EndPage 11
ExternalDocumentID oai_doaj_org_article_f3cfc5ae0d84460a8e5ac9fb22987112
PMC10265558
A764014937
37316843
10_1186_s12889_023_16077_w
Genre Clinical Trial Protocol
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations Oklahoma
United States
United States--US
GeographicLocations_xml – name: Oklahoma
– name: United States
– name: United States--US
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: U54 GM104938
– fundername: NCI NIH HHS
  grantid: P30 CA225520
– fundername: ;
  grantid: U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938
GroupedDBID ---
0R~
23N
2WC
2XV
44B
53G
5VS
6J9
6PF
7X7
7XC
88E
8C1
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABJCF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AN0
AOIJS
ATCPS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BGLVJ
BHPHI
BMC
BNQBC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
L6V
M1P
M48
M7S
M~E
O5R
O5S
OK1
OVT
P2P
PATMY
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PYCSY
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7T2
7XB
8FK
AZQEC
C1K
COVID
DWQXO
GNUQQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c564t-4f1c735179f9492fba37e59761b485fbf94bb6eb643fd52d9e86ad48cbd2dc3c3
IEDL.DBID M48
ISSN 1471-2458
IngestDate Wed Aug 27 01:10:23 EDT 2025
Thu Aug 21 18:37:49 EDT 2025
Thu Jul 10 20:00:16 EDT 2025
Fri Jul 25 10:22:17 EDT 2025
Tue Jun 17 22:19:49 EDT 2025
Tue Jun 10 21:21:24 EDT 2025
Thu Apr 03 06:54:28 EDT 2025
Thu Apr 24 23:10:05 EDT 2025
Tue Jul 01 00:56:54 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords COVID-19
Community-engaged intervention
Vaccine hesitancy
Underserved communities
Rural health disparities
Multiphase optimization strategy
Language English
License 2023. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c564t-4f1c735179f9492fba37e59761b485fbf94bb6eb643fd52d9e86ad48cbd2dc3c3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Undefined-1
content type line 23
OpenAccessLink https://doaj.org/article/f3cfc5ae0d84460a8e5ac9fb22987112
PMID 37316843
PQID 2827038878
PQPubID 44782
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_f3cfc5ae0d84460a8e5ac9fb22987112
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10265558
proquest_miscellaneous_2826217592
proquest_journals_2827038878
gale_infotracmisc_A764014937
gale_infotracacademiconefile_A764014937
pubmed_primary_37316843
crossref_citationtrail_10_1186_s12889_023_16077_w
crossref_primary_10_1186_s12889_023_16077_w
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-06-14
PublicationDateYYYYMMDD 2023-06-14
PublicationDate_xml – month: 06
  year: 2023
  text: 2023-06-14
  day: 14
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC public health
PublicationTitleAlternate BMC Public Health
PublicationYear 2023
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 16077_CR21
16077_CR25
IA Doherty (16077_CR14) 2021; 16
16077_CR29
16077_CR27
16077_CR28
E Nguyen (16077_CR23) 2022; 6
M Gwadz (16077_CR12) 2022; 22
JW Mold (16077_CR33) 2014; 12
LM Collins (16077_CR26) 2004; 5
16077_CR4
16077_CR3
16077_CR6
16077_CR30
16077_CR5
RD Hubach (16077_CR20) 2022; 22
16077_CR31
JW Mold (16077_CR34) 2014; 9
16077_CR8
NM Davoodi (16077_CR7) 2020; 6
16077_CR9
16077_CR13
16077_CR19
16077_CR17
KA Matthews (16077_CR10) 2021; 37
KH Nguyen (16077_CR11) 2021; 70
T Morrison (16077_CR22) 2022; 22
MJ Cima (16077_CR18) 2022; 40
ZJ Nagykaldi (16077_CR35) 2017; 30
R Robinson (16077_CR15) 2022; 9
LM Collins (16077_CR24) 2016; 20
JW Mold (16077_CR32) 2008; 21
NJ Patterson (16077_CR16) 2022; 22
16077_CR2
16077_CR1
References_xml – ident: 16077_CR9
– ident: 16077_CR28
– ident: 16077_CR30
– volume: 5
  start-page: 185
  issue: 3
  year: 2004
  ident: 16077_CR26
  publication-title: Prev Sci
  doi: 10.1023/B:PREV.0000037641.26017.00
– ident: 16077_CR19
  doi: 10.1016/j.vaccine.2022.12.050
– ident: 16077_CR13
  doi: 10.1007/s40615-022-01471-8
– ident: 16077_CR4
  doi: 10.1080/13548506.2020.1750663
– ident: 16077_CR6
  doi: 10.1111/jrh.12481
– volume: 37
  start-page: 272
  issue: 2
  year: 2021
  ident: 16077_CR10
  publication-title: J Rural Health
  doi: 10.1111/jrh.12555
– volume: 22
  start-page: 503
  issue: 1
  year: 2022
  ident: 16077_CR16
  publication-title: BMC Public Health
  doi: 10.1186/s12889-022-12900-y
– volume: 9
  start-page: 169
  year: 2014
  ident: 16077_CR34
  publication-title: Implement Sci
  doi: 10.1186/s13012-014-0169-x
– volume: 22
  start-page: 7128
  issue: 2
  year: 2022
  ident: 16077_CR20
  publication-title: Rural Remote Health
– volume: 12
  start-page: 233
  issue: 3
  year: 2014
  ident: 16077_CR33
  publication-title: Ann Fam Med
  doi: 10.1370/afm.1624
– ident: 16077_CR25
– ident: 16077_CR2
– volume: 6
  start-page: 233372142093616
  year: 2020
  ident: 16077_CR7
  publication-title: Gerontol Geriatr Med
  doi: 10.1177/2333721420936168
– ident: 16077_CR17
  doi: 10.1016/j.japh.2022.01.013
– volume: 16
  start-page: e0248542
  issue: 11
  year: 2021
  ident: 16077_CR14
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0248542
– ident: 16077_CR8
– ident: 16077_CR29
– volume: 22
  start-page: 1235
  issue: 1
  year: 2022
  ident: 16077_CR12
  publication-title: BMC Public Health
  doi: 10.1186/s12889-022-13576-0
– ident: 16077_CR27
– ident: 16077_CR31
– volume: 40
  start-page: 5523
  issue: 37
  year: 2022
  ident: 16077_CR18
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2022.07.045
– ident: 16077_CR21
  doi: 10.1016/j.ypmed.2022.107415
– volume: 21
  start-page: 334
  issue: 4
  year: 2008
  ident: 16077_CR32
  publication-title: J Am Board Fam Med
  doi: 10.3122/jabfm.2008.04.080006
– volume: 30
  start-page: 583
  issue: 5
  year: 2017
  ident: 16077_CR35
  publication-title: J Am Board Fam Med
  doi: 10.3122/jabfm.2017.05.170035
– ident: 16077_CR3
– volume: 22
  start-page: 7140
  issue: 3
  year: 2022
  ident: 16077_CR22
  publication-title: Rural Remote Health
– ident: 16077_CR1
– volume: 9
  start-page: 416
  issue: 1
  year: 2022
  ident: 16077_CR15
  publication-title: Humanit Soc Sci Commun
  doi: 10.1057/s41599-022-01439-3
– volume: 20
  start-page: 197
  issue: Suppl 10 1
  year: 2016
  ident: 16077_CR24
  publication-title: AIDS Behav
  doi: 10.1007/s10461-015-1145-4
– volume: 6
  start-page: e39109
  issue: 12
  year: 2022
  ident: 16077_CR23
  publication-title: JMIR Form Res
  doi: 10.2196/39109
– ident: 16077_CR5
– volume: 70
  start-page: 217
  issue: 6
  year: 2021
  ident: 16077_CR11
  publication-title: MMWR Morb Mortal Wkly Rep
  doi: 10.15585/mmwr.mm7006e3
SSID ssj0017852
Score 2.3936324
Snippet Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have...
Background Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer...
BackgroundOklahoma’s cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer...
Abstract Background Oklahoma’s cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore,...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1146
SubjectTerms Clinical trials
Collaboration
Communication
Community
Community involvement
Community-engaged intervention
COVID-19
COVID-19 - epidemiology
COVID-19 - prevention & control
COVID-19 diagnostic tests
COVID-19 Testing
COVID-19 Vaccines
Demographic aspects
Design optimization
Education
Educational materials
Evaluation
Factorial design
Focus groups
Health care disparities
Humans
Immunization
Intervention
Leadership
Multiphase
Multiphase optimization strategy
Oklahoma - epidemiology
Optimization
Pandemics
Public health
Randomized Controlled Trials as Topic
Rural areas
Rural health
Rural health care
Rural health disparities
Social aspects
Study Protocol
Underserved communities
Underserved populations
Vaccine hesitancy
Vaccines
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yT4KI31ZPGUFQkXLbNk1T39bV4xR0BW_l3kKaD2-5vfZwux76P_o_OZO2yxZBX3xbmumSdCbz0f7yG8ae5tLkEyNFnIRXN7YkEIB3MaXuqcUAqH1AW3wURwv-_iQ_2Wn1RZiwjh64e3AHPjPe5NpNrMTKZaKly7UpfZWmWC0nob9wijFvKKb67weFzNPhiIwUB2v0wgQNSrOYCNWK-HIUhgJb_58-eScojQGTOxHo8Aa73qeOMO2mfJNdcfUtdq177wbdcaLb7Ndsejw7ihef4Ls29NF8_QqIi6FBhQMmqKABo5Ntzpc_nYUeqL7Cn6F9BxAM_itgUggd0vAUgxw06FbO-_OasO7obH_A8w_zz8cvwA_oLmgb6LnDHbgBNwLLHVDlmmSWNSWq-Lez-Zd3b-KkHGYKm4tWnzkUgPnZShNy6Q5bHL6l9fQtG2KTC97G3CemyIj2y5e8TH2ls8JhzSKSisvcV3i1qoSrMA_yFo2hdFJoy6WpbGpNZrK7bK9uanefgfdcyERbYxLLCy1KVxXa-DTzzkh0RRFLBg0q0_OZU1uNlQp1jRSq07pCraugdXUZsZfbey46No-_Sr8mw9hKEhN3uID2qXr7VP-yz4g9I7NS5C9wekb3xx5wkcS8paaF4FSmZkXE9keSuM_NeHgwTNX7mbXCgrkgPp9CRuzJdpjuJOxc7ZpNkBFYeOYlzuVeZ8fbJWWhcRnPIiZHFj5a83ikXp4GFnLc3ILI4h78j6f0kF1NaXdSUyi-z_babxv3CLO9tnocNvZv11ZV3A
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9RAFB60vggiWi-NVhlBUJHQzW0y8UXW1VIFXcGu7NswmUu7dJusTdai_9H_5DmTybpB6FvInIQZcq6Tb75DyPOMq2ykOAsjt3WjCwQBWBNi6h5rCIDSOrTFF3Y0Sz_Ns7nfcGs8rLL3ic5R61rhHvkBlAY5Mpfk_O3qR4hdo_Dvqm-hcZ3cQOoyhHTl803BhY3n4_6gDGcHDfhiBAjFSYi0anl4OQhGjrP_f8-8FZqGsMmtOHR4h9z2CSQdd1_8Lrlmql3svexxGrvkVrcTR7sDRvfIn8n4eHIUzr7Sn1Lhb_TmDUV2hhpUgELKSiWFeKXr88Vvo6mHri_h0jX0oAiMP6GQJtIOe3gKYY_W4GjO_QlO2nQEt7_oy8_Tb8evqO3xXrStqWcTN9T0M6SLLZhlgzKLClNXeO1k-v3j-zAq-pnS9aqVZwYE6PRsKRHLdJ_MDj_genwTh1BlLG3D1EYqT5AIzBZpEdtSJrmBKoZFZcozW8LdsmSmhMzIalCPwnAmdcpVqWOtEpU8IDtVXZk9Qq1NGY-kVirSaS5ZYcpcKhsn1igOzikgUf81hfIM59hoYylcpcOZ6DRAgAYIpwHiMiCvN8-sOn6PK6XfoZJsJJGb292oL06EN3VhE2VVJs1Ic6i1R5KbTKrClnFcQHUaxQF5gSom0IPA9JT0ByFgkcjFJcY5S7FwTfKA7A8kwfLVcLhXUuE9TyP-2UlAnm2G8UlE01WmXjsZBqVoVsBcHnY6vVlS4lqZpUlA-EDbB2sejlSLU8dLDubOkD7u0dXzekxuxmiD2AAq3Sc77cXaPIHMri2fOvP9C5A7ULU
  priority: 102
  providerName: ProQuest
Title CATCH-UP vaccines: protocol for a randomized controlled trial using the multiphase optimization strategy (MOST) framework to evaluate education interventions to increase COVID-19 vaccine uptake in Oklahoma
URI https://www.ncbi.nlm.nih.gov/pubmed/37316843
https://www.proquest.com/docview/2827038878
https://www.proquest.com/docview/2826217592
https://pubmed.ncbi.nlm.nih.gov/PMC10265558
https://doaj.org/article/f3cfc5ae0d84460a8e5ac9fb22987112
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1tb9MwELb2IqFJCPFOYFRGQgKEAs2b7SAh1JaVgbR1Giuq-BI5jr1V65LRF8b4j_wn7pykNGLwxariS2Snz_nunPNzhDyNhIraSjDXs1s3WYxJAEa76Lr7GRhAaWy2xT7bHYafRtFojdTljqoXOLsytMN6UsPp5NWPb5fvQOHfWoUX7PUM1lhM_PEDF-nSuHuxTjbBMnFU1L3wz1cFLiK_Pjhz5X1b5FpgSzmFQcNOWTr_vxftFavVzKhcMVH9m-RG5VvSTgmGW2RN57fJ9XJjjpbnje6QX73OUW_XHR7Q71LhV_XZG4pkDQUggoIHSyUF85UVZ-OfOqNVJvsEftr6HhTz5I8peI20TEU8AStIC1h3zqoDnXRW8t1e0ud7g89HL6ip07_ovKAVubimuk4soeOVrMsZyoxz9GThsb3Bl4_vXS-uR0oX53N5qkGADk4nElOb7pJhfwfnU9V0cFXEwrkbGk_xAHnBTBzGvkllwDUENcxLQxGZFK6mKdMpOEomA7TEWjCZhUKlmZ-pQAX3yEZe5PoBocaETHgyU8rLQi5ZrFMulfEDo5WAtcohXv0PJqoiPMe6G5PEBj6CJSUAEgBAYgGQXDjk5fKe85Lu47_SXQTGUhKpuu2FYnqcVJqfmEAZFUndzgSE3m0pdCRVbFLfjyFY9XyHPENYJQhxGJ6S1bkImCRScyUdzkKMYwPukO2GJCwEqtldAzOp9SiBiJoj4Q8XDnmy7MY7Mbku18XCyjCITKMYxnK_xPFySrU6OEQ0EN6Yc7MnH59YmnLQfoZscg__-dBHZMtH7cNSUOE22ZhPF_ox-HjztEXW-YhDK3oetv0PLbLZ3dk_OGzZXZOWVWxoD7tffwOjeFZv
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGeAAJIRi3wAAjgQBN0Zqb4yAhVDqmlV2KRIv6ZhzH3qp1SVlbqvGj-Cf8J85xktIIaW97q5KT6Lg-Phfn83cIeRlxFbUUZ65nt26yBEEARruYuvsZBEBpLNriiO0Nws_DaLhGftdnYRBWWftE66izQuEe-TaUBjEyl8T8w-SHi12j8Otq3UKjNIt9fbGAkm36vrsD8_vK93c_9Tt7btVVwFURC2duaDwVB8hMZZIw8U0qg1hDWs28NOSRSeFqmjKdQqg2GeibaM5kFnKVZn6mAhXAe6-R6xB4W7ii4uGywMNG9359MIez7Sn4fgQk-YGLNG6xu2gEP9sj4P9IsBIKmzDNlbi3e4fcrhJW2i4t7C5Z0_kG9nqucCEb5Fa580fLA033yJ9OG_-OwRf6Uyr8bD99R5ENogCTo5AiU0khPmbF2eiXzmgFlR_DT9tAhCIQ_5hCWkpLrOMJhFlagGM7q06M0mlJqHtB3xz2vvbfUlPjy-isoBV7uaa61pCOVmCdU5QZ5Zgqw2s7vW_dHddLak3pfDKTpxoEaO90LBE7dZ8MrmR6H5D1vMj1I0KNCRn3ZKaUl4WxZIlOY6mMHxitODhDh3j1bApVMapjY4-xsJUVZ6K0AAEWIKwFiIVDtpbPTEo-kUulP6KRLCWRC9xeKM6PReVahAmUUZHUrYxDbd-SXEdSJSb1_QSqYc93yGs0MYEeC9RTsjp4AYNE7i_RjlmIhXIQO2SzIQmeRjVv10YqKk83Ff_WpUNeLG_jk4jey3UxtzIMSt8oAV0elja9HFJgW6eFgUN4w9obY27eyUcnlgcd3AtDurrHl-v1nNzY6x8eiIPu0f4TctPH9YjNp8JNsj47n-unkFXO0md2KVPy_ap9x19vsI68
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CATCH-UP+vaccines%3A+protocol+for+a+randomized+controlled+trial+using+the+multiphase+optimization+strategy+%28MOST%29+framework+to+evaluate+education+interventions+to+increase+COVID-19+vaccine+uptake+in+Oklahoma&rft.jtitle=BMC+public+health&rft.au=Janitz%2C+Amanda+E&rft.au=Neil%2C+Jordan+M&rft.au=Bray%2C+Laura+A&rft.au=Jervis%2C+Lori+L&rft.date=2023-06-14&rft.eissn=1471-2458&rft.volume=23&rft.issue=1&rft.spage=1146&rft_id=info:doi/10.1186%2Fs12889-023-16077-w&rft_id=info%3Apmid%2F37316843&rft.externalDocID=37316843
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2458&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2458&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2458&client=summon